ExAblate transcranial system for Brain Tumor

N/A

Waitlist Available

Research Sponsored by InSightec

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 months

Awards & highlights

This trial is testing whether a new brain cancer treatment is safe. If it is, future studies will test whether it is effective.

Eligible Conditions

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of subjects with Serious and Non-Serious Adverse Events after MRI Guided Focused ultrasound treatment for brain tumors

1Treatment groups

Experimental Treatment

Group I: ExAblate transcranial systemExperimental Treatment1 Intervention

MR Guided Focused Ultrasound

Do I qualify?Apply below to find out

InSightecLead Sponsor

89 Previous Clinical Trials

3,704 Total Patients Enrolled

~1 spots leftby Jun 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.